XPO1 and acute myeloid leukemia: We first knocked down (KD) levels of XPO1 protein expression with CRISPR ribonucleoprotein in the same MOLM-13 cell line model of FLT3-ITD AML as used in screening with three different guides (Figure 2a) and confirmed reduced protein expression via immunoblot analysis (Figure 2b).